Skip to main content
. 2021 Mar 18;57:95–103. doi: 10.1016/j.breast.2021.03.003

Fig. 2.

Fig. 2

Relationship between BMI and Cmin during the first treatment cycle with SC trastuzumab in patients with HER2-positive early breast cancer in real-world practice. Adapted from [37]